The task force cited insufficient evidence as the driver behind the decision to forego recommending supplemental screening. 

These findings warrant serious consideration by physicians caring for pregnant women in the future, as the link between poor mental health and placental development remains “underappreciated.”

The draft update marks a shift from the task force's previous guidelines, which had endorsed screening beginning at age 50.

Researchers suggested these findings could be used as a noninvasive tool in creating more personalized treatment options for patients facing a cancer diagnosis that is invasive in nature. 

The policy changes forbid insurers from saddling patients with out-of-pocket costs for services associated with lung and breast cancer.

Twenty-five state societies have voiced their support for the proposal, being presented at the 2023 ACR Annual Meeting in D.C. 

“These evidence-based updates should spur more-informed doctor-patient conversations and help providers save more lives," the document's lead author said. 

Artificial intelligence applied to portable breast US can reduce about half of unnecessary referrals for benign lesions, experts wrote in Radiology.